Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
|
|
361
|
Tue, 8/1/2017,
12:30 PM -
1:50 PM
|
CC-Ballroom II
|
|
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
|
|
Biopharmaceutical Section
|
|
Organizer(s): Qi Jiang, Amgen Inc.
|
|
TL09:
|
Benefit-Risk Analysis in Medical Development
—
Shuai Yuan, Merck
|
|
TL10:
|
Dose Finding in Oncology Trials: a Discussion on Challenges and Current Methods
—
Zhao Yang, Amgen, Inc.
|
|
TL11:
|
FDA/Industry-Wide Recommended Analyzes and Displays: a Vision Within Reach
—
Sheryl Treichel, Amgen
|
|
TL12:
|
Integrating Data Science and Big Data Concepts and Machine Learning in Drug Safety
—
Melvin Munsaka, Safety Statistics and Observational Res Analytics, Takeda
|
|
TL13:
|
Personalized Endpoints
—
Marian Strazzeri, US Food and Drug Administration
|
